Business Description
Han Biomedical Inc
ISIN : TW0006999006
Total Employee Number:
21Description
Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 9.28 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.49 | |||||
Interest Coverage | 58.98 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 10.65 | |||||
Beneish M-Score | -2.34 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.2 | |||||
3-Year EBITDA Growth Rate | -4 | |||||
3-Year EPS without NRI Growth Rate | 4.4 | |||||
3-Year Book Growth Rate | 11.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.59 | |||||
9-Day RSI | 60.24 | |||||
14-Day RSI | 56.13 | |||||
3-1 Month Momentum % | -4.47 | |||||
6-1 Month Momentum % | -10.6 | |||||
12-1 Month Momentum % | -28.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.28 | |||||
Quick Ratio | 7.27 | |||||
Cash Ratio | 5.91 | |||||
Days Inventory | 360.56 | |||||
Days Sales Outstanding | 93.55 | |||||
Days Payable | 64.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.06 | |||||
Dividend Payout Ratio | 0.59 | |||||
Forward Dividend Yield % | 1.8 | |||||
5-Year Yield-on-Cost % | 2.06 | |||||
Shareholder Yield % | -0.6 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 78.13 | |||||
Operating Margin % | 19.49 | |||||
Net Margin % | 17.88 | |||||
EBITDA Margin % | 30.08 | |||||
FCF Margin % | -11.08 | |||||
OCF Margin % | 20.99 | |||||
ROE % | 8.94 | |||||
ROA % | 7.65 | |||||
ROIC % | 23.11 | |||||
3-Year ROIIC % | 1.67 | |||||
ROC (Joel Greenblatt) % | 38.71 | |||||
ROCE % | 11.19 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.87 | |||||
PE Ratio without NRI | 29.87 | |||||
Price-to-Owner-Earnings | 33.05 | |||||
PS Ratio | 5.32 | |||||
PB Ratio | 2.45 | |||||
Price-to-Tangible-Book | 2.45 | |||||
Price-to-Operating-Cash-Flow | 25.33 | |||||
EV-to-EBIT | 16.62 | |||||
EV-to-EBITDA | 12.87 | |||||
EV-to-Revenue | 3.87 | |||||
EV-to-FCF | -34.93 | |||||
Price-to-Graham-Number | 1.8 | |||||
| Price-to-Net-Current-Asset-Value | 3.23 | |||||
| Price-to-Net-Cash | 4.96 | |||||
Earnings Yield (Greenblatt) % | 6.02 | |||||
FCF Yield % | -2.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Han Biomedical Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 126.209 | ||
| EPS (TTM) (NT$) | 0.971 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 28.65 | ||
| 14-Day RSI | 56.13 | ||
| 14-Day ATR (NT$) | 0.538709 | ||
| 20-Day SMA (NT$) | 28.369047 | ||
| 12-1 Month Momentum % | -28.14 | ||
| 52-Week Range (NT$) | 26.285714 - 46.666666 | ||
| Shares Outstanding (Mil) | 23.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Han Biomedical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Han Biomedical Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.500000 Cash Dividend | 2026-08-03 | 27.81 (+0.00%) | ||
| 1.05:1 Stock Split | 2026-08-03 | 27.81 (+0.00%) | ||
| TWD 0.571429 Cash Dividend | 2025-08-07 | 45.65 (+6.72%) | ||
| 1.16:1 Stock Split | 2025-08-07 | 45.65 (+6.72%) | ||
| TWD 0.390908 Cash Dividend | 2024-09-04 | 31.35 (-6.87%) | ||
| 1.04761:1 Stock Split | 2024-09-04 | 31.35 (-6.87%) |
Show
Entries
Han Biomedical Inc Frequently Asked Questions
What is Han Biomedical Inc(ROCO:6999)'s stock price today?
The current price of ROCO:6999 is NT$29.00. The 52 week high of ROCO:6999 is NT$46.67 and 52 week low is NT$26.29.
When is next earnings date of Han Biomedical Inc(ROCO:6999)?
The next earnings date of Han Biomedical Inc(ROCO:6999) is .
Does Han Biomedical Inc(ROCO:6999) pay dividends? If so, how much?
The Dividend Yield %  of Han Biomedical Inc(ROCO:6999) is 2.06% (As of Today), Highest Dividend Payout Ratio of Han Biomedical Inc(ROCO:6999) was 0.59. The lowest was 0.34. And the median was 0.47. The  Forward Dividend Yield % of Han Biomedical Inc(ROCO:6999) is 1.8%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Han Biomedical Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers